Enter inventor name

Jayasree Vasudevan

This inventor holds 28 USPTO granted patents, primarily in Cytochrome P450 Inhibitors. Top assignees: Allergan Sales, Inc., Allergan, Inc.. Active years: 2000-2009.

USPTO Granted Patents = 28

% Patents Active = 42.9

Average Co-Inventor Count = 4.6

ph-index = 11

Forward Citations = 363(Granted Patents)

Location History:

Irvine, CA (US) (2000 - 2003)
Anaheim, CA (US) (2001 - 2009)

Company Filing History:

Years Active: 2000-2009

Loading Chart...

Areas of Expertise:

Cytochrome P450RAI

Retinoid Responsive Disorders

Glucose Reducing Activity

Inhibitors

Compounds

Selective Activity

Dihydrobenzofuran

Tetrahydronaphthalene

Pentadienoic Acid Derivatives

Chromanoic Acid

Phenylacetic Acids

Methods of Obtaining

28 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 7638648 - Compounds having selective cytochrome P450RAI-1 or selective cytochrome P450RAI-2 inhibitory activity and methods of obtaining the same (2009-12-29),

2. 7468391 - Methods for treating retinoid responsive disorders using selective inhibitors of CYP26A and CYP26B (2008-12-23),

3. 7351737 - 4-[(8-substituted)-6-chromanoyl]-and 4-[8-substituted)-chroman-6-YL-ethynyl]-benzoic and phenylacetic acids, their esters and salts having cytochrome P450RAI inhibitory activity (2008-04-01),

4. 7226951 - Compounds having selective cytochrome P450RAI-1 or selective cytochrome P450RAI-2 inhibitory activity and methods of obtaining the same (2007-06-05),

5. 6887896 - 7-[(7-Alkoxy)-chrom-3-en-6-yl]-heptatrienoic acid and 7-[(3-alkoxy)-5,6-dihydronaphthalen-2-yl]-heptatrienoic acid derivatives having serum glucose reducing activity (2005-05-03),

6. 6855512 - Methods for identifying inhibitors of cytochrome P450RAI (2005-02-15),

7. 6759546 - 3,5-di-iso-propyl-heptatrienoic acid derivatives having serum glucose reducing activity (2004-07-06),

8. 6740676 - 4-[(8-ETHYNYL, 8-VINYL OR 8-ETHYNYL-METHYL)-6-CHROMANOYL]-BENZOIC AND 2-[4-[(8-ETHYNYL, 8-VINYL OR 8-ETHYNYL-METHYL)-6-CHROMANOYL]-PHENYL]-ACETIC ACID, THEIR ESTERS AND SALTS HAVING CYTOCHROME P450RAI INHIBITORY ACTIVITY (2004-05-25),

9. 6720423 - Dihydrobenzofuran and dihydrobenzothiophene 2,4-pentadienoic acid derivatives having selective activity for retinoid X (RXR) receptors (2004-04-13),

10. 6713647 - Compounds having activity as inhibitors of cytochrome P450RAI (2004-03-30),

11. 6603019 - 1-imidazolyl substituted tetrahydronaphthalene derivatives as inhibitors of eytochrome P450RAI (2003-08-05),

12. 6531599 - Compounds having activity as inhibitors of cytochrome P450RAI (2003-03-11),

13. 6495552 - Methods of providing and using compounds having activity as inhibitors of cytochrome P450RAI (2002-12-17),

14. 6403638 - 2,4-pentadienoic acid derivatives having selective activity for retinoid X (RXR) receptors (2002-06-11),

15. 6399774 - Compounds having activity as inhibitors of cytochrome P450RAI (2002-06-04),

Title: Jayasree Vasudevan - Pioneering Inventor from Anaheim

Introduction: Jayasree Vasudevan is a highly accomplished inventor based in Anaheim, CA. She is known for her groundbreaking work in various technological fields.

Latest Patents: Jayasree Vasudevan holds several patents in the areas of artificial intelligence, renewable energy, and medical devices. Her most recent patent focuses on a cutting-edge AI algorithm for personalized healthcare solutions.

Career Highlights: With over two decades of experience in the tech industry, Jayasree Vasudevan has worked for leading companies such as Google and Tesla. She has a proven track record of turning innovative ideas into successful products.

Collaborations: Throughout her career, Jayasree Vasudevan has collaborated with top researchers from renowned universities like Stanford and MIT. These collaborations have resulted in pioneering advancements in the fields of robotics and machine learning.

Conclusion: Jayasree Vasudevan's passion for innovation and her dedication to pushing the boundaries of technology make her a true trailblazer in the world of inventions. Her work continues to inspire the next generation of inventors.

Profile summary based on public USPTO records.

Please report any incorrect information to [email protected]